Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

A post-marketing surveillance study of a human rabies vaccine in China (2020–2024)

Yisheng Jun’an® rabies vaccine exhibits a favorable safety profile with mild-to-moderate reactions, support its use in post-exposure prophylaxis, supporting its use in post-exposure prophylaxis.

Zhijie Cui, Lianfu Wang, Zhiyuan Ran et al. · 0 citations